Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
The Parathyroid Glands00:59

The Parathyroid Glands

The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identifying the metabolic profile of Hashimoto's thyroiditis from the METHAP clinical study.

Scientific reports·2025
Same author

Glucagon-Like Peptide-1 Receptor Agonist-Experienced Adults with Type 2 Diabetes Switching to Once-Weekly Semaglutide in a Real-World Setting: SURE Program Post Hoc Analysis.

Advances in therapy·2024
Same author

Oral Semaglutide Use in Type 2 Diabetes: A Pooled Analysis of Clinical and Patient-Reported Outcomes from Seven PIONEER REAL Prospective Real-World Studies.

Diabetes therapy : research, treatment and education of diabetes and related disorders·2024
Same author

Novel Fatty Acid Biomarkers in Psoriasis and the Role of Modifiable Factors: Results from the METHAP Clinical Study.

Biomolecules·2024
Same author

Deoxynivalenol triggers the expression of IL-8-related signaling cascades and decreases protein biosynthesis in primary monocyte-derived cells.

Mycotoxin research·2024
Same author

Real-World Use of Oral Semaglutide in Adults with Type 2 Diabetes: The PIONEER REAL Switzerland Multicentre, Prospective, Observational Study.

Diabetes therapy : research, treatment and education of diabetes and related disorders·2024
Same journal

MCT1 inhibition reprograms Treg metabolism via ABC transporters: implications for tumor immunity and the prognosis of acute myeloid leukemia patients.

European journal of medical research·2026
Same journal

Delayed bedtime on workdays is associated with an increased prevalence of gallstones: a population-based study.

European journal of medical research·2026
Same journal

Salvianolic acid B attenuates post-cardiac arrest cerebral ischemia-reperfusion injury via activation of the Nrf2 signaling pathway.

European journal of medical research·2026
Same journal

Clinical value of sputum galactomannan testing in the diagnosis of invasive pulmonary aspergillosis among chronic obstructive pulmonary disease patients.

European journal of medical research·2026
Same journal

Integrative analysis reveals luteolin's molecular targets and mechanisms in pancreatic cancer treatment.

European journal of medical research·2026
Same journal

Non-linear association between cardiometabolic index and helicobacter pylori infection: a cross-sectional study.

European journal of medical research·2026
See all related articles

Related Experiment Video

Updated: May 30, 2026

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging
07:12

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging

Published on: August 17, 2022

Transient hyperthyroidism after surgery for secondary hyperparathyroidism: a common problem.

Gottfried Rudofsky1, M Tsioga, P Reismann

  • 1Division of Endocrinology and Clinical Chemistry, Department of Medicine, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany. gottfried_rudofsky@med.uni-heidelberg.de

European Journal of Medical Research
|August 5, 2011
PubMed
Summary
This summary is machine-generated.

Transient hyperthyroidism is common after parathyroidectomy for secondary hyperparathyroidism (SHP). Thyroglobulin (Tg) levels can help identify this self-limiting condition, preventing unnecessary treatments.

More Related Videos

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
05:12

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy

Published on: May 12, 2023

Related Experiment Videos

Last Updated: May 30, 2026

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging
07:12

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging

Published on: August 17, 2022

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
05:12

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy

Published on: May 12, 2023

Area of Science:

  • Endocrinology
  • Surgical Oncology
  • Nephrology

Background:

  • Postoperative hyperthyroidism is common after parathyroidectomy for primary hyperparathyroidism (PHP).
  • Its occurrence, clinical course, and diagnostic markers in secondary hyperparathyroidism (SHP) are largely unknown.
  • This study investigates these aspects in SHP patients.

Purpose of the Study:

  • To evaluate the frequency and clinical course of postoperative hyperthyroidism following SHP surgery.
  • To determine the diagnostic value of thyroglobulin (Tg) in this context.

Main Methods:

  • 40 patients undergoing parathyroidectomy for SHP were studied.
  • Thyroid stimulating hormone (TSH), free triiodothyronine (fT3), free thyroxine (fT4), and Tg were measured preoperatively and on days 1, 3, 5, 10, and 40 post-surgery.
  • Clinical evaluation for hyperthyroid signs/symptoms was performed at each visit.

Main Results:

  • 77% of patients showed biochemical evidence of hyperthyroidism post-surgery, despite normal preoperative levels.
  • TSH levels decreased significantly (p=0.0015), while fT3 and fT4 levels increased.
  • Thyroglobulin (Tg) levels rose significantly (p<0.001), correlating with TSH, fT3, and fT4 levels.
  • All thyroid-related laboratory values normalized by day 40.

Conclusions:

  • Transient hyperthyroidism is frequent after parathyroidectomy for SHP.
  • Thyroglobulin (Tg) serves as a suitable marker for this condition.
  • Awareness of this self-limiting disorder is crucial to avoid inappropriate treatment.